DexCom Inc (DXCM) stock saw a decline, ending the day at $77.72 which represents a decrease of $-1.20 or -1.52% from the prior close of $78.92. The stock opened at $79.21 and touched a low of $77.33 ...
Shares of DexCom Inc. DXCM slipped 1.52% to $77.72 Friday, on what proved to be an all-around mixed trading session for the ...
器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载近日，全球领先的连续血糖监测仪（CGM）龙头Dexcom宣布，已向智能戒指制造商Ōura投资7500万美元（约折合5.4亿人民币），并达成战略 ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...
The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...
DexCom的地位尤为引人注目，因为它在大盘股中脱颖而出，目前交易价格比52周高点低49%，而大多数大盘成长股仅比52周高点低1-3%。美银证券指出，如果公司的执行符合2025年的预期，DexCom提供了更大的估值倍数扩张潜力。
高估值背后，是Oura出色的商业化表现。根据前段时间公布的数据，Oura的智能戒指已经销售了250多万枚，今年的销量额将翻一番，达到5亿美金。而且，根据CEO Tom Hale的说法，Oura的利润率远高于传统硬件制造商，甚至接近软件公司。
The stock's fall snapped a three-day winning streak.
“行业观察者”是我们针对人工智能、XR、元宇宙和Web3等前沿科技而设立的专栏，主要分享这些领域中的新兴企业或者创业者们的故事。智能戒指制造商Oura获得了美国连续血糖监测（CGM）巨头Dexcom领投的7500万美元融资，并建立战略合作伙伴关系，现 ...
Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...
来自MSN13 天
Dexcom Ventures对Oura Health进行战略投资近日，知名投资机构Dexcom Ventures宣布于2024年11月20日对芬兰智能穿戴监测健康设备研发商Oura Health进行战略投资。 Oura ...
Calibration is entirely optional with the Dexcom G7 and is not typically required for most users due to the system’s high ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈